Oncopeptides AB (publ) announced that Sofia Heigis who will move from the CCO role to take on the CEO role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.695 SEK | -0.92% | -6.26% | -64.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.82% | 55.6M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Announces Sofia Heigis to Move from the CCO Role to CEO Role